Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.082 AUD -3.53% Market Closed
Market Cap: 85m AUD
Have any thoughts about
Percheron Therapeutics Ltd?
Write Note

Wall Street
Price Targets

PER Price Targets Summary
Percheron Therapeutics Ltd

Wall Street analysts forecast PER stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PER is 0.221 AUD with a low forecast of 0.141 AUD and a high forecast of 0.284 AUD.

Lowest
Price Target
0.141 AUD
72% Upside
Average
Price Target
0.221 AUD
170% Upside
Highest
Price Target
0.284 AUD
246% Upside
Percheron Therapeutics Ltd Competitors:
Price Targets
SANOFI
Sanofi India Ltd
36% Upside
000100
Yuhan Corp
19% Downside
600750
Jiang Zhong Pharmaceutical Co Ltd
44% Upside
069620
Daewoong Pharma
38% Upside
AVDL
Avadel Pharmaceuticals PLC
109% Upside
VRNA
Verona Pharma PLC
6% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
53% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Percheron Therapeutics Ltd

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -7%. The projected CAGR for the next 3 years is 161%.

-7%
Past Growth
161%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PER's stock price target?
Price Target
0.221 AUD

According to Wall Street analysts, the average 1-year price target for PER is 0.221 AUD with a low forecast of 0.141 AUD and a high forecast of 0.284 AUD.

What is Percheron Therapeutics Ltd's Revenue forecast?
Projected CAGR
161%

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -7%. The projected CAGR for the next 3 years is 161%.

Back to Top